MedTrace Logo

Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's A Pilot Study

NCT02303756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-06-07

No results posted yet for this study

Summary

The primary aim is to evaluate the efficiency of capsule endoscopy (CCE) in in the detection of neoplasms compared to conventional colonoscopy in persons participating in the Danish screening program for colorectal cancer with a positive fecal occult blood with the colonoscopy being the gold standard.

Conditions

  • Rectal Bleeding

Interventions

DEVICE

Pillcam® COLON Capsule

colonoscopy

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Niels Qvist, professor · Odense University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-07-31
Completion
2016-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303756 on ClinicalTrials.gov